News Release

 

Back
 

AmerisourceBergen Names Leonardo DeCandia Senior Vice President, Supply Chain Management

04/26/04

VALLEY FORGE, Pa.--(BUSINESS WIRE)--April 26, 2004--AmerisourceBergen Corporation (NYSE:ABC), one of the largest pharmaceutical services companies in the U.S., today named Leonardo (Len) DeCandia, 44, Senior Vice President, Supply Chain Management, effective immediately. In this new role, Mr. DeCandia will help lead the delivery of value added services to our manufacturer and healthcare provider partners including the procurement of all products and services within the AmerisourceBergen Drug Corporation. He will be responsible for designing and implementing strategies to improve the efficiency and integrity of the supply chain and for driving the continued evolution in supplier relationships. Mr. DeCandia will report directly to Terrance Haas, President, AmerisourceBergen Drug Corporation.

"We are excited to welcome Len to AmerisourceBergen," said Kurt Hilzinger, President and Chief Operating Officer. "His valuable combination of experience in pharmaceutical product sourcing and manufacturing will bring unique insight to our manufacturer and healthcare provider relationships, and will strengthen our commitment to a collaborative approach with our manufacturer business partners."

Mr. DeCandia brings to AmerisourceBergen over 22 years of experience on the manufacturer side of the pharmaceutical supply channel. He was most recently Vice President, Chief Sourcing Officer, Supply Chain at Hoffmann-LaRoche Inc. Prior to his career at Hoffman-LaRoche, he spent 14 years with Johnson & Johnson.

During the course of his extensive career, Mr. DeCandia has been responsible for engineering, product management, sourcing, procurement, materials management, and logistics.

Mr. DeCandia earned both his BS in Mechanical Engineering and MBA from Rutgers University.

About AmerisourceBergen

AmerisourceBergen (NYSE:ABC) is one of the largest pharmaceutical services companies in the United States. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation, bedside medication safety systems, and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living facilities, reimbursement and pharmaceutical consulting services, and physician education. With more than $47 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 14,000 people. AmerisourceBergen is ranked #22 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.

FORWARD-LOOKING STATEMENTS

This news release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. Forward-looking statements may include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the 2001 merger between AmeriSource Health Corporation and Bergen Brunswig Corporation.

The following factors, among others, could cause actual results to differ materially from those described in any forward-looking statements: competitive pressures; the loss of one or more key customer relationships; customer insolvencies; changes in customer mix; changes in pharmaceutical manufacturers' pricing and distribution policies; regulatory changes; changes in U.S. government policies; failure to integrate the businesses of AmeriSource and Bergen Brunswig successfully; failure to obtain and retain expected synergies from the merger of AmeriSource and Bergen Brunswig; and other economic, business, competitive, regulatory and/or operational factors affecting the business of AmerisourceBergen generally.

More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for fiscal 2003.

AmerisourceBergen is under no obligation to (and expressly disclaims any such obligation to) update or alter any forward looking statements whether as a result of new information, future events or otherwise.


    CONTACT: AmerisourceBergen Corporation, Valley Forge
             Michael N. Kilpatric, 610-727-7118
             mkilpatric@amerisourcebergen.com

    SOURCE: AmerisourceBergen Corporation

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More